A Universal SARS-CoV DNA Vaccine Inducing Highly Crossreactive Neutralizing Antibodies and T Cells

Scientists designed a more universal SARS-CoV-2 DNA vaccine containing receptor binding domain loops from the huCoV-19/WH01, the Alpha, and the Beta variants, combined with the membrane and nucleoproteins.